サマリー

非アルコール性脂肪肝炎の世界市場 2023-2027
非アルコール性脂肪肝炎市場は2022-2027年に11,218.5百万米ドルの成長が予測され、予測期間中のCAGRは40.05%で加速すると予測されます。当レポートでは、非アルコール性脂肪性肝炎市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。肥満とメタボリックシンドロームの有病率の上昇、世界的な高齢化人口の増加、診断技術の進歩などが市場を牽引しています。
Technavio社の非アルコール性脂肪肝炎市場は以下のように分類されます：
流通チャネル別
- オフライン
- オンライン
用途別
- 診断薬
- 治療
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の非アルコール性脂肪性肝炎市場の成長を促進する主な理由の1つとして、患者の関与と教育の高まりを挙げています。また、併用療法の出現とデジタルヘルスソリューションの統合は、市場の大きな需要につながるでしょう。
この調査レポートは、非アルコール性脂肪性肝炎市場を調査・分析し、以下の市場分野を対象としています：
- 非アルコール性脂肪肝炎市場のサイジング
- 非アルコール性脂肪肝炎市場予測
- 非アルコール性脂肪肝炎市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートは、AstraZeneca Plc、BioPredictive S.A.S、Cirius Therapeutics、Enzo Biochem Inc、GENFIT SA、Gilead Sciences Inc.、GlaxoSmithKline Plc、Inventiva S.A.、Madrigal Pharmaceuticals Inc.、Novo Nordisk AS、Prometheus Laboratories、Siemens Healthineers AG、Zydus Lifesciences Ltd.、Intercept Pharmaceuticals Inc.などです。また、非アルコール性脂肪性肝炎市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/non-alcoholic-steatohepatitis-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global non-alcoholic steatohepatitis market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global non-alcoholic steatohepatitis market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Offline - Market size and forecast 2022-2027
o Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 6.4 Online - Market size and forecast 2022-2027
o Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Diagnosis - Market size and forecast 2022-2027
o Exhibit 48: Chart on Diagnosis - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Diagnosis - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Diagnosis - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Diagnosis - Year-over-year growth 2022-2027 (%)
o 7.4 Treatment - Market size and forecast 2022-2027
o Exhibit 52: Chart on Treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Treatment - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Treatment - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Application
o Exhibit 56: Market opportunity by Application ($ million)
o Exhibit 57: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share by geography 2022-2027 (%)
o Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 Canada - Market size and forecast 2022-2027
o Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 99: Market opportunity by geography ($ million)
o Exhibit 100: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 AstraZeneca Plc
o Exhibit 107: AstraZeneca Plc - Overview
o Exhibit 108: AstraZeneca Plc - Product / Service
o Exhibit 109: AstraZeneca Plc - Key news
o Exhibit 110: AstraZeneca Plc - Key offerings
o 12.4 BioPredictive S.A.S
o Exhibit 111: BioPredictive S.A.S - Overview
o Exhibit 112: BioPredictive S.A.S - Product / Service
o Exhibit 113: BioPredictive S.A.S - Key offerings
o 12.5 Cirius Therapeutics
o Exhibit 114: Cirius Therapeutics - Overview
o Exhibit 115: Cirius Therapeutics - Product / Service
o Exhibit 116: Cirius Therapeutics - Key offerings
o 12.6 Enzo Biochem Inc.
o Exhibit 117: Enzo Biochem Inc. - Overview
o Exhibit 118: Enzo Biochem Inc. - Product / Service
o Exhibit 119: Enzo Biochem Inc. - Key offerings
o 12.7 GENFIT SA
o Exhibit 120: GENFIT SA - Overview
o Exhibit 121: GENFIT SA - Product / Service
o Exhibit 122: GENFIT SA - Key offerings
o 12.8 Gilead Sciences Inc.
o Exhibit 123: Gilead Sciences Inc. - Overview
o Exhibit 124: Gilead Sciences Inc. - Product / Service
o Exhibit 125: Gilead Sciences Inc. - Key news
o Exhibit 126: Gilead Sciences Inc. - Key offerings
o 12.9 GlaxoSmithKline Plc
o Exhibit 127: GlaxoSmithKline Plc - Overview
o Exhibit 128: GlaxoSmithKline Plc - Business segments
o Exhibit 129: GlaxoSmithKline Plc - Key news
o Exhibit 130: GlaxoSmithKline Plc - Key offerings
o Exhibit 131: GlaxoSmithKline Plc - Segment focus
o 12.10 Intercept Pharmaceuticals Inc.
o Exhibit 132: Intercept Pharmaceuticals Inc. - Overview
o Exhibit 133: Intercept Pharmaceuticals Inc. - Product / Service
o Exhibit 134: Intercept Pharmaceuticals Inc. - Key offerings
o 12.11 Inventiva S.A.
o Exhibit 135: Inventiva S.A. - Overview
o Exhibit 136: Inventiva S.A. - Product / Service
o Exhibit 137: Inventiva S.A. - Key offerings
o 12.12 Madrigal Pharmaceuticals Inc.
o Exhibit 138: Madrigal Pharmaceuticals Inc. - Overview
o Exhibit 139: Madrigal Pharmaceuticals Inc. - Product / Service
o Exhibit 140: Madrigal Pharmaceuticals Inc. - Key offerings
o 12.13 Novo Nordisk AS
o Exhibit 141: Novo Nordisk AS - Overview
o Exhibit 142: Novo Nordisk AS - Business segments
o Exhibit 143: Novo Nordisk AS - Key offerings
o Exhibit 144: Novo Nordisk AS - Segment focus
o 12.14 Prometheus Laboratories
o Exhibit 145: Prometheus Laboratories - Overview
o Exhibit 146: Prometheus Laboratories - Product / Service
o Exhibit 147: Prometheus Laboratories - Key offerings
o 12.15 Siemens Healthineers AG
o Exhibit 148: Siemens Healthineers AG - Overview
o Exhibit 149: Siemens Healthineers AG - Business segments
o Exhibit 150: Siemens Healthineers AG - Key news
o Exhibit 151: Siemens Healthineers AG - Key offerings
o Exhibit 152: Siemens Healthineers AG - Segment focus
o 12.16 Zydus Lifesciences Ltd.
o Exhibit 153: Zydus Lifesciences Ltd. - Overview
o Exhibit 154: Zydus Lifesciences Ltd. - Business segments
o Exhibit 155: Zydus Lifesciences Ltd. - Key offerings
o Exhibit 156: Zydus Lifesciences Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 157: Inclusions checklist
o Exhibit 158: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 159: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 160: Research methodology
o Exhibit 161: Validation techniques employed for market sizing
o Exhibit 162: Information sources
o 13.5 List of abbreviations
o Exhibit 163: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global non-alcoholic steatohepatitis market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on Application - Market share 2022-2027 (%)
Exhibits45: Data Table on Application - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Diagnosis - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Diagnosis - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Diagnosis - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Diagnosis - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Treatment - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Treatment - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Treatment - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Treatment - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Application ($ million)
Exhibits57: Data Table on Market opportunity by Application ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share by geography 2022-2027 (%)
Exhibits60: Data Table on Market share by geography 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity by geography ($ million)
Exhibits100: Data Tables on Market opportunity by geography ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AstraZeneca Plc - Overview
Exhibits108: AstraZeneca Plc - Product / Service
Exhibits109: AstraZeneca Plc - Key news
Exhibits110: AstraZeneca Plc - Key offerings
Exhibits111: BioPredictive S.A.S - Overview
Exhibits112: BioPredictive S.A.S - Product / Service
Exhibits113: BioPredictive S.A.S - Key offerings
Exhibits114: Cirius Therapeutics - Overview
Exhibits115: Cirius Therapeutics - Product / Service
Exhibits116: Cirius Therapeutics - Key offerings
Exhibits117: Enzo Biochem Inc. - Overview
Exhibits118: Enzo Biochem Inc. - Product / Service
Exhibits119: Enzo Biochem Inc. - Key offerings
Exhibits120: GENFIT SA - Overview
Exhibits121: GENFIT SA - Product / Service
Exhibits122: GENFIT SA - Key offerings
Exhibits123: Gilead Sciences Inc. - Overview
Exhibits124: Gilead Sciences Inc. - Product / Service
Exhibits125: Gilead Sciences Inc. - Key news
Exhibits126: Gilead Sciences Inc. - Key offerings
Exhibits127: GlaxoSmithKline Plc - Overview
Exhibits128: GlaxoSmithKline Plc - Business segments
Exhibits129: GlaxoSmithKline Plc - Key news
Exhibits130: GlaxoSmithKline Plc - Key offerings
Exhibits131: GlaxoSmithKline Plc - Segment focus
Exhibits132: Intercept Pharmaceuticals Inc. - Overview
Exhibits133: Intercept Pharmaceuticals Inc. - Product / Service
Exhibits134: Intercept Pharmaceuticals Inc. - Key offerings
Exhibits135: Inventiva S.A. - Overview
Exhibits136: Inventiva S.A. - Product / Service
Exhibits137: Inventiva S.A. - Key offerings
Exhibits138: Madrigal Pharmaceuticals Inc. - Overview
Exhibits139: Madrigal Pharmaceuticals Inc. - Product / Service
Exhibits140: Madrigal Pharmaceuticals Inc. - Key offerings
Exhibits141: Novo Nordisk AS - Overview
Exhibits142: Novo Nordisk AS - Business segments
Exhibits143: Novo Nordisk AS - Key offerings
Exhibits144: Novo Nordisk AS - Segment focus
Exhibits145: Prometheus Laboratories - Overview
Exhibits146: Prometheus Laboratories - Product / Service
Exhibits147: Prometheus Laboratories - Key offerings
Exhibits148: Siemens Healthineers AG - Overview
Exhibits149: Siemens Healthineers AG - Business segments
Exhibits150: Siemens Healthineers AG - Key news
Exhibits151: Siemens Healthineers AG - Key offerings
Exhibits152: Siemens Healthineers AG - Segment focus
Exhibits153: Zydus Lifesciences Ltd. - Overview
Exhibits154: Zydus Lifesciences Ltd. - Business segments
Exhibits155: Zydus Lifesciences Ltd. - Key offerings
Exhibits156: Zydus Lifesciences Ltd. - Segment focus
Exhibits157: Inclusions checklist
Exhibits158: Exclusions checklist
Exhibits159: Currency conversion rates for US$
Exhibits160: Research methodology
Exhibits161: Validation techniques employed for market sizing
Exhibits162: Information sources
Exhibits163: List of abbreviations